Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 18,697 | 19,065 | 18,381 | 20,012 | 21,244 |
| Operating Income | -18,697 | -19,065 | -18,381 | -20,012 | -21,244 |
| Other Income | 1,208 | 897 | 703 | 933 | 1,233 |
| Pre-tax Income | -17,489 | -18,168 | -17,678 | -19,079 | -20,011 |
| Net Income Continuous | -17,489 | -18,168 | -17,678 | -19,079 | -20,011 |
| Net Income | $-17,489 | $-18,168 | $-17,678 | $-19,079 | $-20,011 |
| EPS Basic Total Ops | -5.76 | -5.60 | -5.92 | -7.68 | -8.16 |
| EPS Basic Continuous Ops | -5.76 | -5.60 | -5.86 | -7.71 | -8.13 |
| EPS Diluted Total Ops | -5.76 | -5.60 | -5.92 | -7.68 | -8.16 |
| EPS Diluted Continuous Ops | -5.76 | -5.60 | -5.86 | -7.71 | -8.13 |
| EBITDA(a) | $-18,223 | $-18,570 | $-17,886 | $-19,517 | $-20,751 |